Clinicopathological correlates and prognostic significance of maspin expression in 450 patients after potentially curative resection of node-positive colonic cancer

Histopathology

Volumn 56, Issue 3, 2010, Pages 319-330

  Fung, Caroline L S ^a   Chan, Charles ^b   Jankova, Lucy ^a   Dent, Owen F ^b   Robertson, Graham ^a   Molloy, Mark ^c   Bokey, Les ^b   Chapuis, Pierre H ^b   Lin, Betty P C ^b   Clarke, Stephen J ^b  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

Author keywords

Cancer; Colon; Maspin; Survival

Indexed keywords

MASPIN;

AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CELL NUCLEUS; COLON CANCER; COLORECTAL CANCER; CYTOPLASM; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE INTESTINE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGISTER; RETROSPECTIVE STUDY; TISSUE MICROARRAY;

ADENOCARCINOMA; AGED; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; PROGNOSIS; SERPINS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77449088787     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03479.x     Document Type: Article

References (42)

1. Sheng S. A role of novel serpin maspin in tumour progression: the divergence revealed through efforts to converge. J. Cell. Physiol. 2006 209 631 635.
2. Al-Ayyoubi M, Schwartz BS, Gettins PG. Maspin binds to urokinase-type and tissue-type plasminogen activator through exosite-exosite interactions. J. Biol. Chem. 2007 282 19502 19509.
3. Maass N, Rölver L, Ziebart M, Nagasaki K, Rudolph P. Maspin locates to the nucleus in certain cell types. J. Pathol. 2002 197 274 275.
4. Pemberton PA, Tipton AR, Pavloff N et al. Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surface. J. Histochem. Cytochem. 1997 45 1697 1706.
5. Jiang N, Meng Y, Zhang S, Mensah-Osman E, Sheng S. Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 2002 21 4089 4098.
6. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ, Sager R. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc. Natl. Acad. Sci. USA 1996 93 11669 11674.
7. Zhang M, Volpert O, Shi YH, Bouck N. Maspin is an angiogenesis inhibitor. Nat. Med. 2000 6 196 199.
8. Schaefer JS, Zhang M. Role of maspin in tumor metastasis and angiogenesis. Curr. Mol. Med. 2003 3 653 658.
9. Mohsin SK, Zhang M, Clark GM, Craig-Allred D. Maspin expression in invasive breast cancer: association with other prognostic factors. J. Pathol. 2003 199 432 435.
10. Sood AK, Fletcher MS, Gruman LM et al. The paradoxical expression of maspin in ovarian carcinoma. Clin. Cancer Res. 2002 8 2924 2932.
11. Nakagawa M, Katakura H, Adachi M et al. Maspin expression and its clinical significance in non-small cell lung cancer. Ann. Surg. Oncol. 2006 13 1517 1523.
12. Cho JH, Kim HS, Park CS et al. Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF). Oral Oncol. 2007 43 272 277.
13. Reis-Filho JS, Torio B, Albergaria A, Schmitt FC. Maspin expression in normal skin and usual cutaneous carcinomas. Virchows Arch. 2002 441 551 558. (Pubitemid 35435824)
14. Zheng HC, Wang MC, Li JY, Yang XF, Sun JM, Xin Y. Expression of maspin and kai1 and their clinicopathological significance in carcinogenesis and progression of gastric cancer. Chin. Med. Soc. J. 2004 19 193 198. (Pubitemid 39362507)
15. Ito R, Nakayama H, Yoshida K, Oda N, Yasui W. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality. Oncol. Rep. 2004 12 985 990.
16. Wang MC, Yang YM, Li XH, Dong F, Li Y. Maspin expression and its clinicopathological significance in tumorigenesis and progression of gastric cancer. World J. Gastroenterol. 2004 10 634 637. (Pubitemid 38351526)
17. Terashima M, Maesawa C, Oyama K et al. Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis. Br. J. Cancer 2005 92 1130 1136.
18. Ito Y, Yoshida H, Tomoda C et al. Maspin expression is directly associated with biological aggressiveness of thyroid carcinoma. Thyroid 2004 14 13 18.
19. Shams TM, Samaka RM, Shams ME. Maspin protein expression: a special feature of papillary thyroid carcinoma. J. Egypt. Natl. Canc. Inst. 2006 18 274 280.
20. Zou Z, Anisowicz A, Hendrix MJ et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994 263 526 529.
21. Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJ. Biological functions of maspin. J. Cell. Physiol. 2006 209 617 624.
22. Lonardo F, Li X, Siddiq F et al. Maspin nuclear localization is linked to favorable morphological features in pulmonary adenocarcinoma. Lung Cancer 2006 51 31 39.
23. Blandamura S, Giacomelli L, Leo G, Segato P, Ninfo V. Nuclear maspin detection in renal cell tumours: possible diagnostic role and correlation with p53 status. Histopathology 2006 49 274 282.
24. Surowiak P, Materna V, Drag-Zalesinska M et al. Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates. Int. J. Gynecol. Pathol. 2006 25 131 139.
25. Boltze C. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis. Pathol. Res. Pract. 2005 200 783 790.
26. Bettstetter M, Woenckhaus M, Wild PJ et al. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer. J. Pathol. 2005 205 606 614.
27. Umekita Y, Souda M, Yoshida H. Expression of maspin in colorectal cancer. In Vivo 2006 20 797 800.
28. Song SY, Lee SK, Kim DH et al. Expression of maspin in colon cancers: its relationship with p53 expression and microvessel density. Dig. Dis. Sci. 2002 47 1831 1835.
29. Dietmaier W, Bettstetter M, Wild PJ et al. Nuclear Maspin expression is associated with response to adjuvant 5-fluorouracil based chemotherapy in patients with stage III colon cancer. Int. J. Cancer 2006 118 2247 2254.
30. Zheng H, Tsuneyama K, Cheng C et al. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumour. Anticancer Res. 2007 27 259 266.
31. Newland RC, Chapuis PH, Pheils MT, Macpherson JG. The relationship of survival to staging and grading of colorectal carcinoma. A prospective study of 503 cases. Cancer 1981 47 1424 1429.
32. Newland RC, Chapuis PH, Smyth EJ. The prognostic value of substaging in colorectal carcinoma. A prospective study of 1117 cases with standardized pathology. Cancer 1987 60 852 857.
33. Bokey EL, Chapuis PH, Dent OF, Mander BJ, Bissett IP, Newland RC. Surgical technique and survival in patients having a curative resection for colon cancer. Dis. Colon Rectum 2003 46 860 866.
34. Davis NC, Newland RC. Terminology and classification of colorectal adenocarcinoma: the Australian Clinico-pathological Staging System. Aust. NZ J. Surg. 1983 53 211 221.
35. Darakhshan A, Lin BP, Chan C, Chapuis PH, Dent OF, Bokey EL. Correlates and outcomes of tumor adherence in resected colonic and rectal cancers. Ann. Surg. 2008 247 650 658.
36. Keshava A, Chapuis PH, Chan C, Lin BPC, Bokey EL, Dent OF. The significance of involvement of a free serosal surface for recurrence and survival following resection of clinicopathological stage B and C rectal cancer. Colorect. Dis. 2007 9 609 618.
37. Gabriel WB, Dukes C, Bussey HJR. Lymphatic spread in cancer of the rectum. Br. J. Surg. 1935 23 395 413.
38. Pral F, Nizze H, Barten M. Tumour budding as a prognostic factor in stage I/II colorectal carcinoma. Histopathology 2005 47 17 24.
39. Ueno H, Murphy J, Jass JR et al. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002 40 127 132.
40. Fielding LP, Arsenault PA, Chapuis PH et al. Clinicopathological staging for colorectal cancer: an international documentation (IDS) and an international comprehensive anatomical terminology (ICAT). J. Gastroenterol. Hepatol. 1991 6 325 344.
41. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998 396 643 649.
42. Edmonston TB, Cuesta KH, Burkholder S et al. Colorectal carcinomas with high microsatellite instability: defining a distinct immunologic and molecular entity with respect to prognostic markers. Hum. Pathol. 2000 31 1506 1514.